Packaging | August 17, 2021
SCHOTT and Serum Institute announce JV for pharma packaging
Serum buys 50 per cent stake in Indian joint venture of SCHOTT Kaisha
Serum buys 50 per cent stake in Indian joint venture of SCHOTT Kaisha
A treatment to prevent extreme symptoms and cut hospitalisation
ADG20, a novel monoclonal antibody targeting the spike protein of SARS-CoV-2 and related coronaviruses
The drug is used with other HIV medications to help control HIV infection and it helps to decrease the amount of HIV in one’s body so that the immune system can work better
The company will add a single-use assembly production unit at its Life Science Center in Molsheim, France.
The partnership is a significant step in delivering advanced cancer therapies to patients.
Subscribe To Our Newsletter & Stay Updated
